Article
Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer.
Cancer epidemiology - 1 Aug 2013
Troy Jesse D, Weissfeld Joel L, Diergaarde Brenda, Youk Ada O, Buch Shama C, Romkes Marjorie, Grandis Jennifer R
Abstract excerpt
INTRODUCTION: Functional polymorphisms in drug metabolizing enzymes (DMEs) may be determinants of survival in oral and oropharyngeal squamous cell carcinoma (OOSCC). METHODS: OOSCC cases (N=159) with a history of either tobacco or alcohol use were genotyped for polymorphisms in eight DMEs. Overal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
